This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Treatment of Primary Cranial Dystonia (Meige’s Syndrome) With Clozapine

Angelika Sieche and Henner Giedke

Published: December 31, 2000

Article Abstract

Letter to the Editor

Sir: Primary dystonia is the most common form of dystonia, a difficult disorder to treat. Although the effect of clozapine on tardive dystonia, a subtype of tardive dyskinesia and a serious side effect of neuroleptic drug treatment, has been reported in several case studies, there are no reports to our knowledge of improvement of primary dystonia resulting from clozapine treatment. We report on a patient with severe and persistent primary cranial dystonia (Meige’s syndrome), which successfully responded to clozapine.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: Movement Disorders

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...